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INTRODUCTION 
 Medicinal Chemistry or Pharmaceutical chemistry is a discipline 
with a traditional focus on organic synthetic chemistry with the broad goals of 
drug discovery and optimization of pharmaceuticals. Medicinal chemistry 
involves the identification, synthesis and development of new chemical 
entities suitable for therapeutic use. The process of establishing new 
pharmaceutical is exceedingly complex and involves the talents of people from 
variety of disciplines, including chemistry, biochemistry, molecular biology, 
physiology, pharmacology, pharmaceutics, and medicine. Thus medicinal 
chemistry occupies a strategic position at the interface of chemistry and 
biology. [1]  
 During the early stages of medicinal chemistry development, scientists 
were primarily concerned with the isolation of medicinal agents found in 
plants. Today, scientists in this field are equally concerned with the creation of 
new synthetic drug compounds, possibly based on newly discovered 
mechanisms. Now medicinal chemist have efficient methods for optimizing 
the potency and the profile of a given active substances. These methods may 
consist of more or less intense approaches such as the synthesis of analogues 
and isomers and isosters, or the modification of ring system. They may also 
rest on computer assisted design, such as identifying pharmacophore by 
molecular modelling or optimizing activity by means of quantitative structure-
activity relationships. 
 Medicinal chemistry concerns the discovery, the development, the 
identification and the interpretation of the mode of action of biologically active 
compounds at the molecular level. Emphasis is put on drugs, but the interest of 
medicinal chemistry is also concerned with the study, identification and 
synthesis of the metabolic products of drugs and related compounds. [2] 
Medicinal chemistry covers the following steps, 
1. In the first stage new active substance or drugs are identified and prepared 
from natural sources, organic chemical reactions or biotechnological 
processes. They are known as lead molecules.  
2. The second stage is optimization of lead molecules to improve the potency, 
selectivity and to reduce toxicity. 
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3. The next stage involves optimization of synthetic route for bulk production 
and modification of pharmacokinetic properties of active substance to render 
it clinically useful.[3] 
 
 Medicinal chemistry is almost always geared toward drug discovery and 
development. Development is an intense, lengthy and an interdisciplinary 
endeavour. Drug discovery is mostly portrayed as a linear, consecutive process 
that starts with target and lead discovery, followed by lead optimization and pre-
clinical in vitro and in vivo studies to determine if such compounds satisfy a 
number of pre-set criteria for initiating clinical development. [4] 
 
IN-SILICO DRUG DESIGN 
 Traditionally, scientists identify new drugs either by fiddling with 
existing drugs or by testing thousands of compounds in a laboratory. Such a 
development processes has resulted in high attrition rates with failures 
attributed to poor pharmacokinetics (40%), lack of efficacy (31%), animal 
toxicity (10%), adverse effect in humans (9%), and various commercial and 
miscellaneous factors. Using a structure-based strategy, researchers have an 
initial advantage. They start with a computerized model of the detailed, three-
dimensional structure of the lock and of its key (the natural molecule called a 
substrate, which fits into the lock, triggering viral replication). Then scientists 
try to design a molecule that will plug up the lock to keep out the substrate 
key. Knowing the exact three-dimensional shape of the lock, scientists can 
discard any of the small molecules that are not the right size or shape to fit the 
lock. They might even be able to design a small molecule to fit the lock 
precisely. Such a molecule may be a starting point for pharmaceutical 
researchers who are designing a drug. 
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RATIONAL DRUG DESIGN 
 Rational drug design has begun to replace the old methods; 
rational drug design is a more streamlined process that requires careful 
consideration of the target of the drug as well as the drug itself. This method 
of drug design uses special equipment to examine the three-dimensional 
structure of a drug target and then find a compound that can interact with the 
target. Rational drug design therefore requires significant knowledge of 
chemistry as well as biology, because chemical interactions between drugs and 
their targets are what determine whether a drug is biologically active. [6] 
  
Rational drug design often involves the use of molecular design 
software, which researchers use to create three-dimensional models of drugs 
and their biological targets. For this reason, the process is also known as 
computer-aided drug design. It saves a great amount of time and money in 
R&D projects. [7] 
  
A drug target, or biological target, is usually one of two types. The first 
type is a molecule in the human body that causes disease when it is defective 
in some way. The second is a molecule from a disease-causing 
microorganism. Drug development involves discovering or designing new 
chemical compounds that interact with these targets in a beneficial way, such 
as by interacting with cholesterol to remove it from the body or by interacting 
with a virus to cause its death. 
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Techniques 
 
• Molecular Docking and Virtual Screening: Molecular docking is a 
computer simulation procedure to predict the conformation of      receptor-
ligand complex, where the receptor is usually a protein or a nucleic acid 
molecule (DNA or RNA) and the ligand is either a small molecule or another 
protein. It can also be defined as a simulation process where a ligand position 
is estimated in a predicted or predefined binding site. Docking is one of main 
tools for virtual screening procedures, where a library of several compounds is 
“docked” against one drug target and returns the best hit. Structure databases, 
such as Protein Data Bank (PDB) and Worldwide Protein Data Bank 
(wwPDB) have over 50,000 protein structures, many of these structures may 
be considered as potential drug targets.  
• Molecular Dynamics: The prediction of the evolution of molecular 
systems over time, the study of protein conformation, protein-protein 
interactions, the simulation of biological membranes. 
• Quantum Mechanics: The study of chemical reactions, the effects of 
substitutions on electronic properties and reactivity of molecules. 
• QSAR (Quantitative structure-activity relationship): The ability of 
predicting biological properties of molecules without even the need of 
knowing their target 
• Homology Modelling: predicting the structures of proteins that has not 
been yet crystallised. [8] 
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CYCLO-OXYGENASE 
 Cyclooxygenase (COX) - An enzyme that is responsible for the 
formation of prostanoids (prostaglandins, prostacyclins, and thromboxanes) 
each involved in the inflammatory response. 
 
The COX enzyme contains two active sites: 
• A Cyclooxygenase site- where arachidonic acid is converted into PGG2 
(hydroperoxy endoperoxide prostaglandin G2). The reaction proceeds through 
H atom abstraction from arachidonic acid by a tyrosine radical generated by 
the peroxidase active site. Two O2 molecules then react with the arachidonic 
acid radical, yielding PGG2. 
• A heme with peroxidase activity- responsible for the reduction of 
PGG2 to PGH2, 
Two Forms of Cyclooxygenase (COX) 
 Two different COX enzymes existed, known as COX-1 and COX-2. 
Cyclooxygenase-1 (COX-1) is known to be present in most tissues, in the GIT, 
COX-1 maintains the normal lining of the stomach. Cyclooxygenase-2 (COX-
2) is primarily present at sites of inflammation. Selective COX 2 inhibitors 
may give good anti-inflammatory activity. [9] 
  
Fig 2- Crystallographic model of Cyclooxygenase-2 
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14 ALPHA DEMETHYLASE 
 14 alpha demethylase is a cytochrome P450 enzyme that involved in the 
steroid production. It is the main target for antifungal drugs, inhibiting the 
production of ergosterol. The inhibition of 14 alpha demethylase leads to the 
depletion of ergosterol and accumulation of steroid precursors, including 14 
alpha methylated steroids (lanosterol, 14, 14- dimethyl zymosterol) resulting in 
the formation of plasma membrane with altered structure and function. [9] 
   
Fig 3- Crystallographic model of 14 α- demethylase 
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ANALGESICS 
 An analgesic may be defined as a drug bringing about insensitivity to 
pain without loss of consciousness. The pain has been classified in to the 
following types: physiological, inflammatory, and neuropathic. The first is the 
most common, for ex. touching a hot object or getting a cut. Inflammatory 
pain can be initiated in a wide variety of ways, such as infection and tissue 
injury. The last type is due to injury to the peripheral of central nervous system 
(CNS). [10] 
 Several classes of pain relieving drugs are there, the three major classes 
of drugs used to manage pain are opioids, NSAIDs, and acetaminophen. The 
consideration of naturally occurring and synthetic analgesic is facilitated 
greatly by dividing them into 2 groups; (a) morphine and related compounds 
and (b) the antipyretics and anti-inflammatory analgesics. 
 Prostaglandin plays a major role in inflammatory processes. The 
NSAIDs inhibit PGs synthesis in several tissues. NSAIDs strongly inhibit the 
conversion of arachidonic acid into prostaglandin E2 (PGE2). This occurs at 
the stage of conversion of arachidonic acid, released by the action of 
phospholipase A2 on damaged tissues, by prostaglandin H2 synthase called 
Cyclooxygenase to the cyclic to the endoperoxides PGG2 and PGH2. These are 
known to cause vasoconstriction and pain. They in turn, are converted in part 
to PGE2 and PGF2α, which can cause pain and vasoconstriction. [11]   
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SUBJECT INTRODUCTION 
Benzimidazole 
    
N
N
H  
 All the heterocyclic compounds have a great interest in pharmaceutical 
chemistry. Out of these heterocyclic compounds the benzfused heterocyclic 
compound that is benzimidazole and its derivatives have wide varieties of 
biological activity. In addition to that the benzimidazole have played a very 
important role in the development of theory in heterocyclic chemistry and also 
extensively in organic synthesis. [12] 
 Benzimidazole is an important pharmacophore and privileged structure 
in medicinal chemistry. Literatures surveys show that among the 
benzimidazole derivative 2-subsituted ones are found to be pharmacologically 
more potent and hence the design and synthesis of 2-susituted benzimidazole 
are the potential area of the research.  
Extensive biochemical and pharmacological studies have confirmed that their 
derivatives are active against various strains of microorganism. The reason for 
a special interest of researchers towards benzimidazole derivatives has been 
5,6-dimethyl benzimidazole which is a constituent of naturally occur vitamin-
B12. Vit B12 capable of inducing the growth of bacteria, benzimidazole 
component and some of its derivatives depress the bacterial growth. Due to the 
structural similarity to purine, antibacterial ability of benzimidazole is 
explained by their competition with purines resulting in inhibition of the 
synthesis of bacterial nucleic acid and proteins. [13, 14] 
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Compounds containing Benzimidazole nucleus [6] 
As antiulcer agents 
N
N
H
S
H3CO O
N
CH3
OCH3CH3
N
N
H
S
O
N
CH3
CH3 OCH2CH2CH2OCH3
  
 Omeprazole      Rabeprazole 
  
N
N
H
S
O
N
CH3
OCH2CF3 
  Lansoprazole 
Analgesic agent 
   
N
N
O
COEt
N
CH2CH2C(CN)Ph2 
  Benzitramide 
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As anthelmintic agents 
N
N
H
N
S
  
O
N
H
N
NH
O
CH3O  
  Thiabendazole    Mebendazole 
 
N
N
H
S
CH3
NH
O
CH3O  
  Albendazole 
Fig 4- Compounds containing Benzimidazole nucleus.  
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REVIEW OF LITERATURE 
1. Alan R.Kartritzky et al., [15] (1988) done the lithiation of N- N-(Dialkyl 
amino) methyl (aminal) derivatives of imidazole, benzimidazole and pyrazole 
which occurs smoothly at the 2-, 2- and 5-positions, respectively, on treatment 
with n-butyl lithium in ether or tetrahydrofuran. Reaction with electrophiles 
and subsequent facile acid-catalyzed hydrolysis of the protecting group 
provides 2-substituted imidazoles, 2-substituted benzimidazoles and 3(5)-
substituted pyrazoles in good overall yields. 
 
  
N
N
H
E
 
 
2. M.Hasan et al., [16] (1989) concluded that when β Unsaturated carboxylic 
acids reacted with unsubstituted o-phenylenediamine under Philip’s reaction 
gave benzodiazapinone as expected and crotonic acid reacts with 4-nitro-o-
phenylenedimine to form benzimidazole. The products were identified and 
their structure was confirmed with the help of elemental analysis. These results 
indicate that not only the structure of unsaturated carboxylic acid, but also the 
substituent present in the ring of o-phenylenediamine influence the mechanism 
of Philip’s reaction. 
 
  
N
N
H
X
 
3. Mohammad R.Mohammadizadeh et al.,[17] (2010) had introduced trifluro 
acetic acid as commercially available, inexpensive and effective catalyst for 
the selective and eco-compatible synthesis of 2-aryl-1-arylmethyl-1H,3-
benzimidazoles via condensation reaction of o-phenylenediamine and aromatic 
aldehydes in ethanol/water at room temperature. 
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N
N
Ar-
Ar-  
 
4. Abdullah GM Al-Sehemi et al., [18] (2005) had synthesized the novel 
isothiocyanate and azide derivatives by the reaction between naproxenoyl 
chloride 2 and nucleophilic reagent ammonium thiocyanate. Interaction of 
isothiocyanate with 1,2-phenylenediamine and anthranilic acid has produced 
the corresponding benzimidazole and 3,1-benzoxacine derivatives 
respectively. Treatment of acid azide with p-toluidine afforded urea derivative. 
The novel quinazolinone was synthesized by acylation of methyl anthranilate 
with acid chloride followed by treatment with hydrazine hydrate. 
 
  
N
NH
NH
O
OMe
 
 
5. M.C Sharma, et al., [19](2010) had reacted prepared schiff bases like 4’-{2-[4-
[2-(substituted-phenyl)-4-oxo-thiazolidin-3-yl]-phenyl}benzoimidazol-1-yl-
methyl}-biphenyl-2-carboxylic acids with mercapto acetic acid and 4’-bromo 
methyl biphenyl-2 carboxylic acid and all synthesized compounds are screened 
for angiotensin(A II). Receptor antagonist antihypertensive activity with 
biphenyl carboxylic acid Schiff’s basesthiazolidine-4-one shows goods activity 
compared with losartan and telmisartan. 
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N
N
O
OH
N
S
O
R2
R3
R1
 
 
6. Mohamed Al Messmary et al.,[20] (2010) prepared 2-substituted 
benzimidazoles by reaction of substituted benzoic acid with o-
phenylenediamine and the products were treated with secondary amines in 
presence of formaldehyde in order to synthesize Mannich bases. The final 
products were characterized by physical and spectral analysis. 
 
   
N
N X
N
R
R
 
       R=CH3 
       R=CH2CH3 
       R=Ph 
 
7. M.C Sharma et al., [21] (2010) had synthesized a series of substituted 
benzimidazoles [2-(substituted-phenyl)-6-methoxy-1-[2’-(1H-tetrazole-5-yl)-
biphenyl-4-ylmethyl]-1H-benzimidazole] from 4-methoxy-1,2-
phenylenediamine and different substituted carboxylic acids in the presence of 
BF3.OEt2  as a catalyst with biphenyl tetrazole. Synthesized compounds have 
been evaluated for antihypertensive activity direct and indirect methods and 
confirmed by IR, NMR, MS and elemental analysis. 
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N
N
R
OMe
N
NH
N N
 
 
8. Kiumars Bahrami et al., [22] (2008) synthesized 2-substituted benzimidazoles 
and benzothiazoles and this offers short reaction times, large scale synthesis, 
easy and quick isolation of products, excellent chemo selectivity, and excellent 
yields as main advantages. 
 
9. Pinar Alcil et al., [23] (2009) had studied synthesis and illumination of 8 
compounds that were expected to display antifungal and antibacterial activity 
in addition to interaction with DNA. It was performed by heating o-
phenylenediamine and derivatives with succinic acid and malonic acid in 4N 
HCl. Reactions with succinic acid yields bis-benzimidazole derivative. 
Reactions with malonic acid yield benzimidazole derivatives. During analysis 
it was found that compound 1 requires higher concentration and longer time to 
be able to interact with DNA than comparing with compound 5. All 
compounds were examined for antibacterial activity. Compound 7 was 
effective against E.coli and compound 5 against Enterococcus faecalis.7 and 8 
were effective against Candidia albicans. 
 
 
 
N
NH
y
x
N
NH
y   
N
N
H
y
x
 
(1)     (5) 
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10. Sachin V.et al., [24] (2011) developed a novel approach for the synthesis of 2-
substituted benzimidazole via a tandem reaction following sp3 C-H 
functionalization. Here they reported a simple, efficient and tandem oxidative 
dehydrative coupling reaction of N-benzylbenzene-1,2-diamine in the presence 
of oxidant tert-butyl hydro peroxide(TBHP) in solvent acetonitrile to give 
substituted  benzimidazole. 
 
    
N
N
H
Ar-
 
 
11. Simone Budow et al., [25] (2009) evaluated the anti viral activity of a series of 
benzimidazole and substituted benzimidazole β-L-and β-D-
2’deoxyribonucleosides against RNA and DNA viruses including HIV-1, 
BVDV, YFV, DENV-2, WNV etc. Several other syntheses of compounds, 
stereo selective glycosilation of anions and certain crystalline structures of 
compounds were also reported. 
       
N
N
Br
O
OH
OH
 
 
12. Santhosh.S.Chhajed et al.,[26] (2011) had synthesized substituted 
benzimidazole by the reaction between 2-methyl 1-H benzimidazole, with 
different (un)/ substituted aldehydes to form 2-(un)/substituted styryl/vinyl-
1H-benzimidazole. Structures and purity were determined by elemental 
analysis and TLC respectively. Synthesized compounds were screened for 
their antioxidant properties. Results shown that two of them active same as 
standard ascorbic acid while other three are more active than ascorbic acid. 
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N
N
H
R1
R2
 
R1= -H, -NO2 
R2= -H, -CH3, -C6H5, -C6H4Cl (o,m,p), -C6H4OH (o,p), -C6H4NO2 
 
 
13. K.Niknam et al., [27] (2007) reported a microwave assisted method for the 
synthesis of 2-substituted benzimidazole in presence of alumina-
methanesulphonic acid (AMA). In addition, by the direct reaction of 
phenylenediamine and dicarboxylic acid, new bis-benzimidazoles were formed 
in excellent yields. 
 
N
N
H
R(Ar)
, 
N
N
H
Y+
N
NH
 
Y= N , CH2-CH2, CH2-S-CH2, CH2-O-CH2 
 
14. Mashoda Hasan et al., [28] (1997) had condensed methyl crotonic acid with 4-
chloro-o-phenylenediamine in 4N HCl yielded 5-chloro-2(1-
isobutenyl)benzimidazole and 7-chloro-4,4-dimethyl-1,3,4,5-tetrahydro-2H-
1,5-benzodiazepin-2-one.condensation of methacrylic acid with 4-chloro-o-
phenylenediamine in 4N HCl yielded 5-chlooro-2(2-propenyl)benzimidazole. 
The structures where confirmed with the help of mass and 1HNMR spectral 
analysis. 
 
 
15. Kavitha C.S.Achar et al., [29] (2010) had synthesized 2-methyl-
aminobenzimidazole derivative (1-11) by the reaction of 2-(chloro methyl)-
1H-benzimidazole derivatives with primary aromatic amines. The compounds 
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were characterized by IR, 1H NMR, 13C NMR, GC-MS and elemental analysis 
and were screened for analgesic and anti-inflammatory activities on acetic acid 
induced writhing in mice and carrageenan induced paw oedema in rats. 
Compounds(7) and (2) showed a potent analgesic and anti-inflammatory 
activities compared with standard drug nimesulide respectively. The other 
compounds showed good analgesic and anti-inflammatory activities. 
     
N
N
H
NH
R'
R
 
R=H, Br, NO2 
R’=H, Cl, Br, CH3, OCH3 
 
16. Panneer Selvam et al., [30] (2011) had synthesized and characterized 2-
substituted benzimidazole derivatives by IR, 1H NMR, 13C NMR, Mass and 
elemental analysis. Compounds were screened for anti bacterial and anti 
fungal activities. The minimum inhibitory concentration (MIC) was 
determined by agar streak dilution method. 1-(4-(1H-benzo[d]imidazol-
2yl)phenyl)-3-chloro-4-(4-nitrophenyl)acetidin-2-one was found to exhibit 
potent and some others exhibit moderate activity against the bacterial and 
fungal organism tested. 
N
N
H
N
R
Cl
O
N
N
H
N
S
R
O
 
R=C6H4NO2, C6H4Cl, C6H4OCH3, C6H4CH3 
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17. Ahmed O.H.El-Nezhawy et al., [31] (2009) had synthesized a series of 2-
methyl-N-substituted-benzimidazoles, bearing hydroxypyrrolidinone-5-yl or 
hydroxylpyrrolidine-2-yl, 2,3:5,6-di-O-isopropylidine-α-D-mannofuranoside, 
2,3,5,6-tetrahydroxy-α-D-xylo-heptofuranos-5-ulose, 3-O-benzyl-6,7-dideoxy-
1,2-dihydroxy-α-D-xylo-heptofuranose-5-ulose, 1,2,5,6-tetrahydroxy-α-D-
glucofuranose sugar moieties. These compounds were obtained in good yields 
from 2-methyl N-(trichloroacetamidomethyl) benzimidazole as a donor and 
carbohydrate residues as acceptor precursors in the presence catalytic amount 
of trimethylsilyl trifluoromethanesulfonate (TMSOTf) as Lewis acid. Out of 
16 synthesized compounds 6 showed significant anti-inflammatory and 
analgesic activities. 
N
N
O
α−d−xylulose
 
 
18. Shefali Arora et al., [32] (2011) found out that the side effects of some 
analgesic agents were overcome by achieving an effect at a lower dose. 
Modification of the structure of a known drug had optimized the 
pyrimidobenzimidazole derivatives using molecular modeling studies, using 
the physicochemical parameter and molecular descriptors. The data base was 
subjected to QSAR studies using Chemsketch software version 10.0e and all 
the parameter and descriptors were calculated using TSAR 3D version 3.3 for 
windows. The results of QSAR study suggested that molecule must contain at 
least substituent on R1 and R2 should be NO2 for good analgesic activity. 
   
N
N
H
N
H
R1
R2
S
R3
R4
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R1= -H, -NO2, -COOH, -C6H5CO, -CH3 
R2= -H, -CH3, -Cl 
R3= -H, -CH3 
R4= -H, -CH3 
 
 
19. V.Mohan Goud et al., [33] (2011) had synthesized benzimidazole derivatives 
like 2-(1H-benzimidazole-2-yl-sulfanyl)-N-(2-hydroxy-5-methylphenyl) 
acetamide, and the structures were confirmed by IR, HNMR and MS. The 
compounds were screened for analgesic and anti-inflammatory activities by 
biological evaluation method and antibacterial activity. Some synthesized 
compounds have shown significant analgesic anti-inflammatory activity and 
moderate antibacterial activity. 
     
N
N
H
S
NH
O
R2
R1
 
R1= -CH3, -H, -NO2, -Cl 
R2= -OH, -NH2, -COCF3 
 
20. Janardan.S.Yadav et al., [34] (2011) had synthesized 2-amino-6-(1H-
benzimidazolle-2-yl)-4-phenyl pyridine-3-carbonitriles by reacting 2-acetyl 
benzimidazoles(1) with substituted benzaldehydes(2) in presence of ethanol to 
furnish substituted chalcones (3a-f).These chalcones were further treated with 
Malononitrile and Ammonium Acetate to afford substituted 2-Amino-6-(1H 
benzimidazol-2-yl)-4-phenyl pyridine-3-carbonitriles(4a-f). The structures 
were confirmed by spectral data and elemental analysis. The compounds were 
screened for antibacterial activity. The results exhibited good antibacterial and 
moderate antifungal activities. 
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N
N
H
N
CN
NH2
R
 
R= -H, -OCH3, -Cl, -N(CH3)2 
 
 
21. Avinash Patil et al., [35] (2008) proven the antiulcer activity as potent inhibitor 
of H+/K+-ATPase of a series of benzimidazole derivatives. The therapeutic 
significance of these drugs for the treatment of peptic ulcer and GIT diseases 
encouraged the development of potent and significant compounds. The 
pathophysiology of disease, structural and molecular chemistry of 
benzimidazole derivatives was also discussed. This study summarizes the 
different derivatives of substituted benzimidazole along with biological 
evaluation and factors that make the drug more specific for proton pump 
inhibitors. 
 
22. A.Anton Smith et al., [36] (2008) had synthesized novel benzimidazole 
derivatives from Ibuprofen with 0-phenylenediamine and was subjected to 
antibacterial activity against Staphylococcus aureus ATCC 250, Pseudomonas 
aeruginosa ATCC 25619, etc and antifungal efficacy against Candida albicans 
RSKK 628. It was shown that benzimidazole derivatives was more effective 
and found more effective and showed antibacterial and antifungal activity 
against the entire organism tested. The MIC was found in the range 25-
100mg/ml on all the microorganisms. 
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N
N
H
 
 
 
23. Thakare P.B et al., [37] (2011) had synthesized new substituted 2-
(pyrimidinylsulphenyl)benzimidazole derivatives from different starting 
material and evaluated against antiulcer anti-secretory activity as a inhibition 
of gastric H+/K+-ATPase by induction of gastric ulcerations experimentally in 
male WISTER rats according to the method. The compound was characterized 
by elemental analysis and IR. The compounds were tested to antiulcer and 
anti-secretory activities. The antiulcer activities were assessed by acetyl 
salicylic acid (ASA) method-induced gastric ulcer. 
     
N
H
N
H
R1
S
N
N
O
R2
 
 
24. Raju B Chaudhari et al., [38] (2011) prepared the derivatives by the 
condensation of O-phenylenediamine with 4-bromobenzoic acid to give 2-(4-
bromophenyl)-1H-benzimidazole which undergoes Heck reaction with alkyl 
acrylates to give the above benzimidazole derivatives. These compounds react 
with electrophiles to give 1N-substituted alkyl/acyl/aroyl/sulphonyl 
derivatives. The antibacterial activities were also checked but the results are 
found to be disappointing. 
     
N
N R1
R  
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R= Methyl, Ethyl, Butyl, Benzyl, Methoxycarbonyl, Phenylsulfonyl 
R1= Methoxycarbonyl, Ethoxycarbonyl,   
 
 
25. Saoussen Hammami et al., [39] (2010) had synthesized new N-pyrazoyl-
benzimidazoles through a two-step reaction using 5,2-aminophenylamino-3-
(2-hydroxy phenyl)-1H-pyrazole as a useful precursor. The compounds were 
characterized by M.S, 1H, 13C and 2D NMR techniques. 
 
N
N
N
N
OH
   O
N N
N
N
R  
R= -CH3, C2H5 
 
26. Rahul R Nagawade et al., [40] (2006) had synthesized substituted 
benzimidazoles by the reaction with 0-phenylenediamine and aldehydes in the 
presence BF3OEt2 as a catalyst in solvent free conditions. They found that the 
method is applicable to aromatic, unsaturated and aliphatic aldehydes and to 
substituted O-phenylenediamine without significant differences. 
 
N
N
H
R'
R
NH2
NH2
R
+ HR'
O
BF3OEt2(cat.)
 
 
 
27. Hiroyuki Nakano et al., [41] (1999) had synthesized novel benzimidazole 
derivatives that suppress histamine release from mast cells, inhibit 5-
lippooxygenase and possess anti-oxidative action. Among the synthesized 
compounds 1-[2-[2(4-hyydroxy-2,3,5-trimethylphenoxy)ethoxy]ethyl]-2-(4-
methyl-1-homopiperazino)benzimidazole potently suppressed histamine 
release from rat peritoneal mast cells triggered by the antigen-antibody 
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reaction, inhibited 5-lipoxygenase in rat basophilic leukemia-1(RBL-1) cells 
and prevented the NADPH-dependent lipid peroxidation induced by Fe3+-ADP 
in rat liver microsomes, in addition to an antagonizing the contraction of 
guinea pig ileum caused by histamine. 
   
N
N
N
N
R1
R2
 
 
28. Anshul Chawla [42] (2011) discussed about the benzimidazole prepared from 
amino acids associated with diverse pharmacological activities such as 
antimicrobial, antiviral, anti-diabetic and anticancer activity. This review is 
deals with the “green” synthesis of benzimidazole derivatives by microwave 
induced reactions. 
 
 
29. Devender Pathak et al., [43] (2010) suggested in this review article that 
benzimidazole derivatives posses biological actions such as antimicrobial, 
anti-inflammatory, anticancer, anticonvulsant, antidepressant, antioxidant, 
radio protective and anti-leishmanial activities. In this review article the SAR 
of benzimidazole derivatives where also discussed to develop newer 
compounds possessing benzimidazole moiety that could be better agents in 
terms of efficacy and safety. 
 
30.  Shefali Arora [44] (2011) found out that compounds of pyrimidine, pyridine, 
and benzimidazole nucleus have wide range of therapeutic uses such as anti 
tubercular, anti cancer, anti-helmintic, anti oxidant and anti microbial 
activities. It was also believed that the presence of >N-C=S linkage is 
responsible for the amoebicidal, anti-convulsant, fungicidal and antiviral 
activities. Various benzimidazole derivatives of o-phenylenediamine, 4,5-
dimethyl-1,2-phenylenediamine, 4-chloro-1,2-phenylenediamine, S-
methylated o-phenylenediamine, S-mehylated-4,5-dimethyl-1,2-
phenylenediamine, S-methylated-4-chloro-1,2-phenylenediamine have been 
synthesized. The derivatives were screened with various bacterial and fungal 
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strains. After the study it was showed that very good activity against the fungal 
strains of Aspergillus niger and Aspergillus japanicus. 
 
     
N
N
H
N
H
R1
R2
S
 
R1= -H, -CH3 
R2= -H, -CH3, Cl 
 
 
31. Davood azarifar et al., [45] (2010) developed a simple procedure for the green 
synthesis of various 2-aryl-1(arylmethyl)-1H-benzimidazoles in high yields by 
acetic acid-promoted condensation of o-phenylenediamine with aldehydes in 
air under microwave irradiation and transition metal catalyst-free conditions. 
 
32. S. O. Podunavac kuzmanovi et al., [46] (2007) had reacted Zinc (II) chloride 
with some 1-benzylbenzimidazole derivatives (L) to give complexes of the 
formula ZnL2Cl2. All the ligands and their zinc (II) complexes were evaluated 
for their in vitro antibacterial activity against Pseudomonas aeruginosa, 
Bacillus cereus, Staphylococcus aureus and Sarcina lutea. The majority of the 
investigated compounds displayed in vitro antimicrobial activity against very 
persistent microorganisms. It was found that all the tested compounds were 
more active against gram-positive than gram-negative bacteria. The minimum 
inhibitory concentration (MIC) was determined for all ligands and their 
complexes. The effect of the structure of the ligands and complexes on the 
antimicrobial activity is discussed. The complexes were found to be more 
toxic than the ligands. 
 
 
 
33. P.C.Santosh et al., [47] (2011) published a review article suggest that 
benzimidazole is an important nucleus and a large variety of 2-substituted 
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benzimidazoles have been to possess antiulcer, antihelminthic, analgesic, anti 
inflammatory, antispasmodic, antihistaminic, antimicrobial, anticancer, 
Cyclooxygenase inhibitor and HIV-1 reverse transcriptase inhibitor activities. 
 
34. Raamanpreet Walia et al., [48] (2011) had reviewed that benzimidazole 
derivatives play an important role in medical field with so many 
pharmacological activities such as antimicrobial, antiviral, antidiabetic, and 
anticancer activity. The potency of these clinically useful drugs in treatment 
encouraged the development of some more potent and significant compounds. 
Benzimidazoles are remarkably effective compounds, extensive biochemical 
and pharmacological studies have confirmed that these molecules are 
effective. They summarized about the chemistry of different derivatives of 
substituted benzimidazoles along with their pharmacological activities. 
 
 
35. Punit P. Seth et al., [49] (2003) had done the preparation and evaluation of 
different 2-amino benzimidazole dimmers as antibacterial agents. The 
biological evaluation indicated that compounds with multiple chloro 
substituent possessed optimal antibacterial activity. 
 
36. M.Shahar Yar et al., [50] (2009) had synthesized a series of pyrazoline and 
phenyl pyrazoline derivatives of benzimidazoles by reacting 1-(1H-
benzimidazole-2yl)-3-(substituted phenyl)-2-propane-1-one with hydrazine 
hydrate and phenyl hydrazine in submitted reactions. All the compounds 
entered for screening at the Tuberculosis Antimicrobial Acquisition and 
Coordination Facility (TAACF) for their in vitro antibacterial activity against 
Mycobacterium Tuberculosis using Microplate Alamar Blue Assay (MABA) 
susceptibility test. The result expressed as MIC in µg/ml. Among the fifteen 
compounds, eight compounds were found to have MIC values less than 10 
µg/ml. These were subjected for cytotoxicity assay in VERO cells to 
determine CC50 values and finally the SI (selectivity index) were calculated. 
2-[5-(4fluorophenyl)-1-phenyl-4,5-dihydro-1H-3-pyrazolyl]-1H-
benzimidazole was considered the best candidate of the series that could be a 
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good starting point to develop new lead compounds in the fight against 
tuberculosis. 
 
 
37. Paris.M.Allen et al., [51] (1970) reported that thiabendazole inhibit the growth 
of Penicillium atrovenetum at 8-10µg/ml. Thiabendazole did not inhibit 
peptide synthesis in cell-free protein synthesizing system. Probably the 
primary site of inhibition is the terminal electron transport system and other 
effects are secondary. 
 
38. Rajesh kumar et al., [52] (2007) had synthesized a series of imidazolines and 
benzimidazoles from various aldehydes and 1,2-diamines in the presence of 
Ceric(IV) ammonium nitrate (CAN). They prepared via one step synthesis 
method. This method is more attractive for organic chemists because of the 
simplicity of the reaction conditions with shorter reaction time and without the 
use of column chromatography to get the pure products in high yield. 
 
 
39. Raquel Dias et al., [53] (2008) reviewed several molecular docking search 
algorithms and the programs which apply such methodologies and  also 
discussed how virtual screening can be optimized, describing methods that 
may increase accuracy of the simulation process, with relatively fast docking 
algorithms. Molecular docking is a computer simulation procedure to predict 
the conformation of a receptor-ligand complex. Each docking programme 
makes use of one or more specific search algorithms, which are the methods 
used to predict the possible conformation of a binary complex. 
 
40. Sabiha Alper et al., [54] (2002) done a detailed investigation on bi- and ter-
benzimidazole derivative revealed that these compounds are new classes of 
topoisomerase I inhibitors that poisons mammalian topoisomerase I. Some 
recent result about new derivatives, some SAR and comparison of activity of 
various functional groups are discussed. In general 5-position of 
terbenzimidazole is an important position for their activity. The presence of 
phenyl, naphthyl or pyridyl groups at this position influence cytotoxicity. In 
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addition to this para substituents at 5-position needed for the activity as 
topoisomerase I poisoning. 
 
 
41. Chhajed.S.S et al., [55] (2010) had designed and novel substituted 
benzimidazoles and docked into active site of Cyclooxygenase II. The ligands 
are designed based on the structure of the receptor, COX II and well known 
NSAID celecoxib. Further in-silico docking analysis of designed ligands was 
performed to predict binding mode, orientation and affinity. Ligands having 
less binding energy are said to possess more affinity for receptor than other 
molecules. 
   
N O
O
R2
O
R1  
R1= -H, -ClC6H4 
R2= -C6H5, -ClC6H4, -NO2C6H4, -CH3, -OHC6H4, -NH2C6H4 
 
42. Sreena.K et al., [56] (2009) had synthesized some benzimidazole derivatives 
and screened for their anthelmintic activity. O-phenylenediamine was 
condensed with acids in presence of polyphosphoric acid and solvents like 
water and HCl and the synthesized compounds were characterized by IR, 
NMR and MS. All the synthesized compounds showed significant 
anthelmintic activity. 
 
 
43. Gulgun Ayhan Kilcigil et al., [57] (2006) had synthesized some benzimidazole 
derivatives and tested their in-vitro antifungal activities against Candida 
albicans, Candida glabrata, Candida krusei. Among the synthesized 
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compounds two of them possessed activity compatible to fluconazole against 
Candida albicans with a MIC of 12.5µg/ml. 
 
N
N
R2
R1
NHNH
S
X
 
R1= -C3H7, -C5H4 
R2= -H, -F 
R3= -H, -Cl 
 
44. Ashish Kumar Tewari et al., [58] (2006) had synthesized two series of N-
substituted-2-substituted benzimidazole derivatives. 1-benzyl-2-substituted 
benzimidazole and 1-(p-chlorophenyl)-2-substituted benzimidazole had been 
synthesized and tested for their antiviral activities. The compounds had been 
screened for Tobacco mosaic viruses and Sunhemp rosette viruses and show 
significant activities. 
 
     
N
N
R1
R  
R= -H, -CH2C6H5, C6H5Cl 
R1= -CH2CH2COOH, -C6H5OH, - (CH2)4COOH, -C6H4COOH 
 
45. K.Vijayakumar et al., [59] (2010) had synthesized a series of novel 
benzimidazole derivatives by the condensation of different diamines with 
anthranilic acids. The subsequent reaction of benzimidazole derivatives had 
been also carried out with different aromatic acid chlorides to get tetrazole 
moieties. These compounds were screened for their potential anticancer, anti-
diabetic, antitumor and anti-asthmatic properties, which exhibited some 
authentic results towards testing organism in-vitro and in-vivo studies. 
 
46. B.Anil Reddy [60] (2009) had synthesized various 2-substituted benzimidazole 
derivatives and subsequent reaction to get the corresponding Mannich bases. 
The formations of the products were confirmed by the analytical and spectral 
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data. The biological evaluation showed that the prepared compounds possess 
anti-inflammatory activity.  
 
     
N
N NH2
N
 
 
 
47. Jat rakesh kumar et al., [61] (2006) had synthesized a new seris no of non 
peptide angiotensin(A-II) receptor antagonist. This 5-substituted (amino)-2-
phenyl-1-(2’carboxy biphenyl-4-yl) benzimidazoles produce potent anti-
hypertensive effect upon oral administration. It had been found out that 2’-
position of biphenyl is essential. Only ortho substituted acids possess both 
high affinity for the AII receptor and oral anti-hypertensive potency. 
 
     
N
N
NH2
R
HOOC
 
 
48. Canan Kus et al., [62] (2003) had synthesized methyl-5(6)-fluro-6(5)-
substituted-1H-benzimidazole carbamate derivatives and their antifungal 
activities were evaluated against Candida albicans. 
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N
N
H
F
R
NH
OMe
O  
R= -Cl, -4-morpholinyl, 1-pyrrolidinyl, 3-methylpiperidin-1-yl 
 
49. Zygmunt Kazimierczuk et al., [63] (2002) synthesized two series of 
benzimidazole derivatives. The first one was based on 5,6-
dinitrobenzimidazole, second one comprises 2-thioalkyl- and thioaryl- 
substituted modified benzimidazoles. Antibacterial and antiprotozoal activities 
of the newly synthesized compounds were studied. Some thioalkyl derivatives 
showed remarkable activity against Stenotrophonomas malthophilia and an 
activity comparable to that of metronidazole against gram positive and gram 
negative bacteria. Out of the tested compounds, 4,6-dichloro-2-(4-
nitrobenzylthio)-benzimidazole showed the most distinct antiprotozoal 
activity.  
 
 
N
N
O2N
O2N
HOHC
CH2OH  
N
N
H
R1
R2
R3
SR4
 
 
50. Srinivas Bethi et al., [64] (2011) had fused the moieties of benzimidazole & 
thiazolidinones and synthesized novel 3-(1H-benzimidazole-2-yl-amino)-2-
phenyl-1,3-thiazolidin-4-one, such 5 compounds are characterized by its 
physical datas and screened for possible CNS activity like gross behavioral 
studies and locomotion activity. Among all the test compounds, compound 
with 4-Chloro substitution on phenyl ring showed more promising depressant 
activity. 
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N
N
H
NH
N
SO
R
 
R= -H, -Cl, -N(CH3)2, -OCH3, -CH3, -OH 
 
51. Ashish Kumar Tewari et al., [65] (2006) had synthesized two series of N-
substituted benzimidazole derivatives viz 1-benzyl-2-substituted 
benzimidazole and 1-(P-Chlorophenyl)-2-substituted benzimidazole and tested 
for Antiviral activities by Tobacco mosaic viruses and Sunhemp rosette 
viruses and show significant activities. 
   
N
N
R
R'  
R= -CH2CH2COOH, -C6H4OH, -C6H4COOH. … 
R’= -H, -CH2C6H5, C6H5Cl 
 
52. Ramaraj sivakumar et al., [66] (2010) done molecular docking of 
benzimidazole containing pyrazoline-5-one derivatives as inhibitor of 14-α-
demethylase which is the enzyme targeted in treatment of fungal infection in 
organisms ranging from humans to plants. The inhibitory activities against 14-
α-demethylase were investigated by molecular docking using the HEX 
docking software. These compounds docked into the active site of 
receptor(PDB code, IE9X) using HEX docking tools and compounds show 
good affinity for the enzyme when compared with the binding energies of 
standard drugs such as clotrimazole and griseofulvin. Among all the designed 
compounds, the compound 7 show more binding energy values. 
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N
N
R
R'
O N
N N
NH
O  
R= -H, -CH3, -CH2C6H5, -CH2CH2COOH, -C6H4COOH, -C6H4OH 
R’= -H, -NO2 
 
53. Parmender Sing Rathee et al., [67] (2011) had synthesized two series of novel 
benzimidazole derivatives. The first one comprises of 2-methyl, second one 
comprises of 2-phenyl substitution on benzimidazole moiety. Seven novel 
benzimidazole derivatives were synthesized and characterized 
physicochemically. The synthesized compounds were screened for 
antimicrobial activity by tube dilution method. Among the synthesized 
compounds four of them showed appreciable antifungal activity. 
   
N
N
O R2
R3
R1
 
R1= -CH3, -CH2C6H5NO2, -CH2C6H5 
R2= -NO2, -H 
R3= -H, -OH 
 
54. P. Shanmugapandian et al., [68] (2010) synthesized a new series of 2-[4-
(azetidin-2-one)-3-Chloro-4-phenyl]-1H-Phenylbenzimidazole and 2-
[(thiazolidin-4-one)-phenyl]-1H-Phenylbenzimidazoles. The synthesized 
compounds were screened for antibacterial, antifungal, analgesic and anti-
inflammatory activity. All the compounds shows significant antimicrobial 
activity compared to the standard, and two of the thiazolidinone derivative 
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shows prominent analgesic anti-inflammatory activity equivalent to 
diclofenac. 
  
N
N
H
N
S
O
R1
R2 R3
 
R1= -H, -OCH3 
R2= -H, -Cl, -OH, -CH3, -N(CH3)2, -OCH3 
R3= -H, -OCH3 
 
 
55. S.L.Khokra et al., [69] (2011) published an article which reveals the different 
actions of benzimidazole; suggesting that benzimidazole is a versatile 
heterocycle possessing a wide spectrum of biological activities like 
antihelminthic, antifungal, anti-allergic, antimicrobial, antiviral, and 
antineoplastic activities and highlights the importance of benzimidazole in 
medicinal world. 
 
56. Ganesh Akula et al., [70] (2011) had synthesized a new series of 3-[1H-
benzimidazole-2-yl-amino]-2-phenyl-1,3-thiazolidin-4-one and screened for 
depressant activity by the gross behavioral studies and the loco motor activity 
method. Among all the five synthesized compounds two of them showed 
excellent depressant activity. 
 
 
57. Harjyoti Thakuria et al., [71] (2008) developed a simple, highly efficient, 
convenient, and one pot solvent free green synthetic method for the synthesis 
of biologically important benzimidazole derivative. They explore the utility of 
simple one pot, solvent free, solid phase grinding method for efficient 
synthesis of biologically active benzimidazole derivatives. 
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58. Peyman Salehi et al., [72] (2006) had developed a highly selective synthesis of 
2-aryl-1-aryl methyl-1H-1,3-benzimidazole from O-phenyl diamine and 
aromatic aldehydes in presence of silica sulfuric acid in ethanol or water. 
 
   
N
N
H
R1
R1
R2
 
R1= -H, -CH3 
R2= -C6H5, -MeOC6H4, -MeC6H4, -ClC6H4, Me2NC6H4 
 
 
59. R. Kalirajan et al., [73] (2010) had synthesized a series of pyrazole derivatives 
of benzimidazole; microwave irradiation and further reaction results in the 
final products. Among the synthesized compounds two of them had shown 
significant anti-cancer activity and all compounds had showed the antibacterial 
activity. 
   
N
N
H
N
H
N
Ar-
 
Ar= -C6H5, -C6H4Cl, -C6H3Cl2, -C6H4NO2, -C6H4OCH3 
 
60. Dijana J.Barna et al., [74] (2007) investigated the antifungal activity of some 
1-benzylbenzimidazole derivatives against yeast Saccharomyces cerevisiae. 
Quantitative structure-activity relationship (QSAR) had been used to study the 
relationship between the antifungal activity and lipophilicity parameter, log P, 
calculated by using CS Chem-Office Software version 7.0 and three high-
quality mathematical models relating the inhibitory activity, log 1/CMIC, and 
log P were defined. The developed QSAR mathematical model is used to 
predict inhibitory activity of the benzimidazole. 
REVIEW OF LITERATURE 
 
Dept. of  Ph. Chemistry  Page 36 
 
   
N
N
R3
R4
R2
R1  
R1= -CH3, -Cl, -F, -OCH3, -CH3 
R2= -H, -NH2 
R3= -CH3, -H 
R4= -CH3, -H 
 
61. Srikanth Gurrala et al., [75] (2011) had adopted a convenient methodology 
for the symmetrical coupling of 2-mercapto benzimidazole derivatives by 
suitable linking agents. The synthesized compounds were screened for 
antifungal activity using Candida albicans by disc diffusion method on nutrient 
agar media and antibacterial activity using DMF as a solvent against the 
organisms, S.aureus and  E.coli using Ketoconazole and Ampicillin as 
standard drug. 
  
N
NH
S
(CH2)n
S N
NH
 
R= -OCH3, -OCHF2 
62. Rakesh R. Somani et al., [76](2009) summarized in the review about oxadiazole, 
a heterocyclic nucleus; suggest that out of its four possible isomers, 1,3,4-
oxadiazole is widely exploited for various applications. They explained about the 
various routes of synthesis and reactions of 1,3,4-oxadiazole and its derivatives 
and focus on their biological potential. 
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AIM OF THE WORK 
 In the present study, the main motto was to develop new chemical 
entities as potential anti-inflammatory, analgesic and antimicrobial agents by 
chemical modification of the 2nd position of prepared benzimidazole by 
different heterocyclic rings. 
 In our attempt, firstly 3-(1H-benzimidazol-2-yl) propanoic acid was 
prepared. Suitable heterocyclics which give potent ligands were identified by 
molecular docking then synthetic approaches based upon the chemical 
modification of the carboxylic group present in the prepared 3-(1H-
benzimidazol-2-yl)propanoic acid with the heterocyclics like pyridazine-3,4-
dione, 2,3-dihydrophthalazine-1,4-dione, 1,3,4-oxadiazole. Furthermore, it has 
been reported in literature that certain compounds bearing these nucleus 
possesses a wide spectrum of activities like analgesic, anti-inflammatory, 
anticonvulsant, antipyretic, antihypertensive, antiviral, antituberculosis, 
antimicrobial, anticancer activities etc. then identification and characterization 
of synthesized compounds by different methods like physical properties (M.P, 
Solubility, Thin layer chromatography) and spectral analysis (IR, NMR). 
 Finally selective pharmacological activities like Antimicrobial, 
Analgesic and Anti-inflammatory activities need to examine.  
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PLAN OF THE WORK 
Step 1: 
 Designing various ligands by substituting different heterocyclic rings 
like phthalazine, triazine, 1, 3, 4- oxadiazole, and pyridazine on benzimidazole 
in order to identify the most potent compounds with the help of molecular 
docking studies. 
Step 2: 
 The most potent compounds which have been identified by molecular 
docking studies were planned to synthesis. 
Step 3: 
 The synthesized compounds were planned to characterized by physical 
data and spectral analysis (IR, HNMR) 
Step 4: 
 Finally all the synthesized compounds were planned to evaluate for 
Antimicrobial, Analgesic and Anti-inflammatory activities. 
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MOLECULAR DOCKING 
EXPERIMENT 
 In the docking studies, the protein sequences for Cyclooxygenase-2 and 
14 α demethylase were taken from NCBI (National Center for Biotechnology 
Information). The sequences were converted into FASTA format. The FASTA 
format sequences were allowed to BLAST (Basic Local Alignment Search 
Tool) data base to identify the PDB code of required protein. The protein 
structure files of Cyclooxygenase-2 and 14α demethylase (PDB code: 6COX, 
3KHM) were taken from Protein Data Bank (www.rcsb.org/pdb) and edited by 
removing the hetero atom. CAST P (Computed Atlas of Surface Toporaphy of 
Protein) server was used to cross check the active pockets on target protein 
molecules. All the ligand molecules were designed and the structure was 
analyzed using Chemoffice2004 software. ACD/ChemSketch software was 
used to draw the chemical structures. Argus lab.exe was used to perform 
molecular docking. Pymolsoftware was used to view the structure and 
calculating the length of the hydrogen bond. 
LIGANDS DESIGNING 
 Various compounds were designed by replacing the carboxylic acid 
group present in the prepared 3-(1H-benzimidazol-2-yl)propanoic acid with 
the heterocyclics like pyridazine, phthalazine, 1,3,4-oxadiazole, pyrazole, 
imidazole, thiazole etc. in order to identify the new ligands. Docking 
simulation was carried out to all the designed compounds against 6COX 
(COX-2 enzyme) and 3KHM (14α demethylase enzyme) by using Argus Lab 
Program and the docking scores of each compound were analyzed. 
FOR ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY- Out of all 
the designed compounds, eight compounds showed good interaction energies 
against 6COX (see table 1). Among them structure containing 1,3,4-
oxadiazole (Ligand1, Ligand 2), pyridazine ( Ligand 6, Ligand 7), and 
phthalazine (Ligand 8) showed highly negative interaction energy. The 
compounds which have highly negative energy were considered as potent 
compounds. 
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FOR ANTIMICROBIAL ACTIVITY- Out of all the designed compounds, 
eight compounds showed good interaction energies against 3KHM (see table 
2). Among them structure containing 1,3,4-oxadiazole (Ligand 2, Ligand 3, 
Ligand 4), pyridazine (Ligand 6), and phthalazine (Ligand 8) showed highly 
negative interaction energy and these compounds were considered as potent 
compounds. 
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STRUCTURE OF LIGANDS DESIGNED 
1,3,4-OXADIAZOLE DERIVATIVES: 
 
N
H
N
O
N
N
NO2   
N
H
N
O
N
N
Cl  
  Ligand 1    Ligand 2 
 
N
H
N
O
N
N
OCH3H3CO   
N
H
N
O
N
N
NH2  
  Ligand 3    Ligand 4 
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N
H
N
O
N
N
SH  
  Ligand 5 
PYRIDAZINE DERIVATIVES: 
N
H
N
O
N
NH
O
O   
N
H
N
O
N
NH
O
O
  Ligand 6     Ligand 7 
PHTHALAZINE DERIVATIVE: 
N
H
N
O
N
NH
O
O  
 Ligand 8  
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Table No 1. DOCKING SCORES (kcal/mol) OF VARIOUS NEWLY 
DESIGNED LIGANDS (1-8) WITH CYCLOOXYGENASE-2 (6COX) 
Sl.no Compound 
code 
Energy level 
(kcal/mol) 
No. of 
hydrogen bond 
Length of 
hydrogen 
bond 
Interacting 
residue 
1 Ligand 1 -10.5347 5 2.5 
2.8 
3.0 
2.9 
3.0 
VAL291 
VAL291 
LEU294 
VAL295 
TRP387 
2 Ligand 2 -12.8915 2 1.9 
3.0 
GLU203 
TRP387 
3 Ligand 3 -10.3525 1 3.0 TRP387 
4 Ligand 4 -9.41254 NIL NIL NIL 
5 Ligand 5 -9.37935 1 3.0 TRP387 
6 Ligand 6 -10.6027    
7 Ligand 7 -11.2328    
8 Ligand 8 -11.8177    
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Table No 2. DOCKING SCORES (kcal/mol) OF VARIOUS NEWLY 
DESIGNED LIGANDS (1-8) WITH 14α-demethylase (3KHM) 
Sl.no Compound 
code 
Energy level 
(kcal/mol) 
No. of 
hydrogen 
bond 
Length of 
hydrogen 
bond 
Interacting 
residue 
1 Ligand 1 -7.16042 2 3.4 
2.5 
GLN294 
LYS248 
2 Ligand 2 -8.91847 1 2.5 ASN213 
3 Ligand 3 -7.90829 2 2.6 
3.0 
LEU214 
ASN213 
4 Ligand 4 -7.49149 2 1.9 
2.6 
GLU204 
ASN213 
5 Ligand 5 -7.45405 2 2.0 
2.4 
GLU204 
ASN213 
6 Ligand 6 -7.63357 3 2.7 
3.0 
1.6 
LEU214 
ASN213 
GLU204 
7 Ligand 7 -6.81676 1 3.0 LEU214 
8 Ligand 8 -7.6645 1 2.1 ASN213 
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BINDING MODE OF VARIOUS LIGANDS WITH COX-2 
ENZYME (6COX) 
Fig 5 
 
Ligand 1 
 
 
Ligand 2 
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Ligand 3 
 
 
Ligand 4 
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Ligand 5 
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BINDING MODES OF VARIOUS LIGANDS WITH 
14 Alpha Demethylase ENZYME (3KHM) 
Fig 6 
 
Ligand 1 
 
Ligand 2 
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Ligand 3 
 
 
Ligand 4 
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Ligand 5 
 
 
Ligand 6 
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Ligand 7 
 
 
Ligand 8 
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SCHEME OF PRESENT WORK 
 
 
NH2
NH2
+
O
OH
O
OH
4N HCl
4 hrs
N
N
H
O
OH
N
N
H
COOC2H5
NH2NH2.H2O
Ethanol
Δ
Conc H2SO4EthanolΔ
N
N
H
CONHNH2
3-(1H-benzimidazol-2-yl)propanoic acid
ethyl 3-(1H-benzimidazol-2-yl)propanoate
3-(1H-benzimidazol-2-yl)propanehydrazide
benzene-1,2-diamine butanedioic acid
 
 
          
 Cont….. 
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N
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N
O
N
NH
O
O
N
H
N
O
N
N
NH2
N
H
N
O
N
N
R
N
H
N
O
N
N
SH
CNBr,
Ethanol
Δ, 8Hr
KOH,
CS2
Ethanol
Δ, 12 Hr
Phthalic anhydride,
Glacial acetic acid
Absolute ethanol
Δ, 3 Hr
Maleic anhydride,
Glacial acetic acid
Absolute ethanol
Δ, 3 Hr
Succinic anhydride,
Glacial acetic acid
Absolute ethanol
Δ, 3Hr
Δ, 55-60 oC
2Hr
R=P-Nitro phenyl (A), P-Chloro phenyl(B), 3,5-Dimethoxy phenyl (C)
POCl3,
RCOOH
(A,B,C)
(D)
(E)
(F)
(G)
(H)
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EXPERIMENTAL WORK 
Chemicals and instruments 
14. Phosphorus oxychloride
15. 4-Nitro benzoicacid
16. 4-Chloro benzoicacid
17. 3,5-Dimethoxy benzoicacid
18. Potassium hydroxide
19. Carbon disulphide
20. Cyanogen bromide
21. Chloroform
22. Benzene
23. Silica gel G
24. DMF
25. DMSO
All the above chemicals and reagents used were analytical grade.
1. o-Phenylene diamine
2. Succininc acid
3. HCl
4. Absolute ethanol
5. Conc.H2SO4
6. Hydrazine hydrate
7. Conc.Ammonia solution
8. Sodium bicarbonate
9. Methanol
10. Succinic anhydride
11. Maleic anhydride
12. Glacial acetic acid
13. Phthalic anhydride
 
 
Instruments Model 
Melting 
point 
apparatus 
VEEGO-VMPT (Silicon 
oil bath) 
FT-IR 
spectrometer 
Perkin elmer 
NMR 
spectrometer 
Bruker-Ultra shield 
(300MHz) 
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SYNTHESIS OF VARIOUS PYRIDAZINE, PHTHALAZINE, 
1,3,4-OXADIAZOLE DERIVATIVES OF BENZIMIDAZOLE 
Synthesis of 3-(1H-benzimidazol-2-yl)propanoic acid (1) 
 o-Phenylenediamine (0.03 mol) and Succinic acid (0.09 mol) dissolved 
in 30 ml of HCl (4N) and the reaction mixture was refluxed for 4 hrs. Cooled 
the mixture and add Ammonia solution (Conc.) to increase the basicity. The 
solid thus precipitated out was filtered washed with cold water and 
recrystallized from absolute ethanol. 
NH2
NH2
+
O
OH
O
OH
4N HCl
4 hrs
N
N
H
O
OH
(1)
 
Synthesis of ethyl 3-(1H-benzimidazol-2-yl) propanoate (2) 
 0.05 mol of 3-(1H-benzimidazol-2-yl) propanoic acid (1) in absolute 
ethanol (10ml), and Conc H2SO4 (1ml) was added. The reaction mixture was 
refluxed for 22hrs. Reaction mixture gave on processing ethyl ester (2). The 
solid obtained was washed with 50 ml of Sodium bicarbonate solution (10%) 
and recrystallized from methanol. 
N
N
H
O
OH
N
N
H
COOC2H5Conc. H2SO4
Ethanol
Δ 22hrs
(2)
 
Synthesis of 3-(1H-benzimidazol-2-yl)propanehydrazide (3) 
 Compound 2 (0.01 mol) and Hydrazine hydrate (0.02 mol) were 
refluxed in absolute ethanol (50 ml) for 20 hrs. The mixture was concentrated, 
cooled and poured in ice cooled water. The solid thus precipitated out was 
filtered, dried and recrystallized from ethanol. 
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N
N
H
COOC2H5
N
N
H
CONHNH2
NH2NH2.H2O
Absolute ethanol
Δ 20hrs
(3)
 
Synthesis of 2-[2-(5-substituted aryl-1,3,4-oxadiazol-2-yl)ethyl]-1H-
benzimidazole (A, B, C) 
 0.001 mol of 3-(1H-benzimidazol-2-yl)propanehydrazide (3) and 
appropriate aromatic acid (0.001 mol) was dissolved in phosphorus 
oxychloride and refluxed for 8 hrs. The reaction mixture was slowly poured 
over crushed ice and kept overnight. The solid thus precipitated was filtered, 
washed with water, dried and recrystallized from ethanol. 
N
N
H
CONHNH2 N
H
N
O
N
N
R
RCOOH
POCl3
Δ 8 hrs
(A,B,C)
 
Synthesis of 1-[3-(1H-benzimidazol-2-yl) propanoyl]-1,2-dihydropyridaz-
ine-3,6-dione (D) 
 A mixture of 3-(1H-benzimidazol-2-yl)propanehydrazide (3) (0.001 
mol) and maleic anhydride (0.001 mol) in 5 ml absolute ethanol, add glacial 
acetic acid (0.005 mol). The reaction mixture was refluxed for 3 hrs. It was 
then cooled and poured into crushed ice. The solid obtained was filtered, 
washed with 50 ml of sodium bicarbonate solution (50 ml) and recrystallized 
from ethanol. 
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N
H
N
O
N
NH
O
O
N
N
H
CONHNH2
O
O
O
5 ml absolute ethanol
glacial acetic acid
(D)
 
Synthesis of 1-[3-(1H-benzimidazol-2-yl)propanoyl]tetrahydropyridazine-
3,6-dione (E) 
 A mixture of 3-(1H-benzimidazol-2-yl)propanehydrazide (3) (0.001 
mol), succinic anhydride (0.001 mol) in 5 ml absolute ethanol and glacial 
acetic acid (0.005 mol) was refluxed for 3 hrs. The reaction mixture was 
cooled and poured into crushed ice. The solid obtained was filtered, washed 
with 50 ml of sodium bicarbonate solution (50 ml) and recrystallized from 
ethanol. 
N
H
N
O
N
NH
O
O
N
N
H
CONHNH2
O
O
O
5 ml absolute ethanol
glacial acetic acid
(E)
 
Synthesis of 2-[3-(1H-benzimidazol-2-yl)propanoyl]-2,3-dihydrophthalaz-
ine-1,4-dione (F) 
 A mixture of 3-(1H-benzimidazol-2-yl)propanehydrazide (3) (0.001 
mol), phthalic anhydride  (0.001 mol) in 5 ml absolute ethanol and glacial 
acetic acid (0.005 mol) was refluxed for 3 hrs. The reaction mixture was 
cooled and poured into crushed ice. The solid obtained was filtered, washed 
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with 50 ml of sodium bicarbonate solution (50 ml) and recrystallized from 
ethanol. 
N
H
N
O
N
NH
O
O
N
N
H
CONHNH2
O
O
O
5 ml absolute ethanol
glacial acetic acid
(F)
 
Synthesis of 5-[2-(1H-benzimidazol-2-yl)ethyl]-1,3,4-oxadiazole-2-thiol (G) 
 A mixture of 0.001 mol of 3-(1H-benzimidazol-2-yl)propanehydrazide 
(3), KOH (0.001 mol) and Carbon disulphide (5 ml) in ethanol (50 ml) was 
refluxed for 12 hrs. The solution was then concentrated, cooled and acidified 
with dilute HCl. The solid thus precipitated was filtered, washed with ethanol, 
dried and recrystallized from ethanol. 
N
N
H
CONHNH2
N
H
N
O
N
N
SH
KOH
CS2
Ethanol
Δ 12 hrs
(G)
 
Synthesis of 5-[2-(1H-benzimidazol-2-yl)ethyl]-1,3,4-oxadiazol-2-amine 
(H) 
 To an ethanolic solution of 3-(1H-benzimidazol-2-yl)propanehydrazide 
(3) (0.001 mol), cyanogens bromide (0.001 mol) was added. The reaction 
mixture was stirred with heating at 55-60 °C for 2 hrs. The resulting solution 
was cooled and it was neutralized with sodium bicarbonate (10%) solution. 
The solid thus precipitated was filtered, washed with water, dried and 
recrystallized from methanol. 
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N
N
H
CONHNH2
N
H
N
O
N
N
NH2
CNBr
Ethanol
Δ 55-60 oC 2hrs
(H)
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PHYSICAL CHARACTERISTICS 
 The synthesized compounds were characterized by the following 
physical properties. 
THIN LAYER CHROMATOGRAPHY 
 The purity of the synthesized compounds was ascertained by TLC. 
Absorbent used : Silica Gel G 
Developing solvent : Benzene:Chloroform(9:1) 
Detecting agent : Iodine vapour. 
Colour of the spot : Brown (iodine vapour) 
Rf values of synthesized compounds were calculated by the following formula, 
Rf= (Distance travelled by the solute) / (Distance travelled by the solvent) 
Rf values of the synthesized compounds were shown in the table No.4. 
MELTING POINT 
 Melting point of the synthesized compounds was determined by open 
capillary tube method. The melting points of the synthesized compounds were 
shown in the table No.4. 
SOLUBILITY 
 At room temperature solubility of the synthesized compounds were 
determined. The solubility of the synthesized compounds was shown in table 
No.4. 
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TABLE NO.3 
PHYSICAL DATA OF SYNTHESIZED COMPOUNDS 
Compound 
code 
Molecular 
formula 
Molecular 
weight 
Colour Nature Percentage 
yield 
A C17H13N5O3 335.32 Cream Powder  95.34 
B C17H13ClN4O3 324.76 Pale white Powder 94.13 
C C19H18N4O3 350.37 Grey Crystalline 85.47 
D C14H12N4O3 284.27 Creamy 
white 
Powder  80.21 
E C14H14N4O3 286.29 Pale white Powder  69.52 
F C18H14N4O3 334.33 Pale white Powder 86.43 
G C11H10N4OS 246.29 Ash  Crystalline 78.53 
H C11H11N5O 229.24 White Powder 80.44 
 
  
PHYSICAL CHARACTERISTICS 
 
Dept. Of Ph. Chemistry  Page 62 
 
TABLE NO.4 
PHYSICAL DATA OF SYNTHESIZED COMPOUNDS 
Compound 
code 
Solubility Melting 
point 
°C 
Rf 
value 
CHCl3 DMF DMSO CH3OH C2H5OH 
A + + + -+ -+ 238-240 0.62 
B + + + -+ -+ 248-250 0.57 
C + + + -+ -+ 190-195 0.72 
D + + + + + 260-265 0.51 
E + + + + + 265-270 0.54 
F + + + + + 273-278 0.65 
G + + + + + 250-254 0.70 
H + + + + + 255-260 0.53 
 
Where + Soluble 
- Insoluble 
-+ slightly soluble 
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INTERPRETATION OF SPECTRA 
COMPOUND A 
N
H
N
O
N
N
NO2  
2-{2-[5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl]ethyl}-1H-benzimidazole 
IR Spectral data [14, 77] 
KBr pellet 
IR value (cm-1) Groups assigned 
2850.68, 2713.95 Alkyl C-H stretching 
1700.67 Aromatic C=C stretching 
717.05, 747.74, 857.17 Aromatic C-H bending 
1522.57 N-H bending 
1295.86, 1312.96, 1338.14 C-N stretching 
1030.03 C-O-C stretching 
1421.03, 1350.45 N=O stretching 
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NMR Data [14, 77] 
DMSO 
δ Value (ppm) Groups assigned 
8.167-8.226 4H, 3,4,5,6Aryl protons 
7.699-7.721 4H, 2,3,5,6Aryl protons 
3.427 1H, NH protons 
8.0167-1.234 4H, CH2 protons 
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COMPOUND B 
   
N
H
N
O
N
N
Cl  
2-{2-[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]ethyl}-1H-benzimidazole 
IR Spectral data [14, 77] 
KBr Pellet 
IR Value (cm-1) Groups assigned 
2842.48 Alkyl C-H Stretching 
1592.68, 1425.96 Aromatic C=C Stretching 
762.30, 853.03 Aromatic C-H Bending 
1684.30 N-H Bending 
1332.30 Aromatic C-N Stretching 
1092.73 C-O-C Stretching 
549.03 C-Cl Stretching 
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NMR Data [14, 77] 
DMSO 
δ Value (ppm) Groups assigned 
7.934-7.955 4H, 3,4,5,6 Aryl protons 
7.564-7.585 4H, 2,3,5,6 Aryl protons 
2.513 1H, NH protons 
0.828-1.236 4H, CH2 protons 
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COMPOUND C 
   
N
H
N
O
N
N
OCH3H3CO  
2-{2-[5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl}-1H-benzimidazole 
IR Spectral data [14, 77] 
KBr Pellet 
IR value (cm-1) Groups assigned 
2959.26 Alkyl C-H Stretching 
1459.22 Aromatic C=C Stretching 
768.01, 726.99 Aromatic C-H Bending 
1351.99, 1308.93 C-N Stretching 
1686.31 N-H bending 
1048.67 C-O-C stretching 
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NMR Data [14, 77] 
DMSO 
δ Value (ppm) Groups assigned 
7.056-7.061 4H, 3,4,5,6 Aryl protons 
6.735-6.747 3H, Dimethoxy aryl 
protons 
3.785 3H, OCH3 protons 
2.509 1H, NH protons 
1.151-1.332 4H, CH2 protons 
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COMPOUND D 
  
N
H
N
O
N
NH
O
O  
1-[3-(1H-benzimidazol-2-yl)propanoyl]-1,2-dihydropyridazine-3,6-dione 
IR Spectral data [14, 77] 
KBr Pellet 
IR Value (cm-1) Group assigned 
2928.13 Alkyl C-H Stretching 
1431.98 Aromatic C=C Stretching 
748.43 Aromatic C-H Bending 
1599.50 C=O Stretching 
1222.37 Alkyl C-N stretching 
1275.66 Aromatic C-N Stretching 
3781.31 N-H Stretching 
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NMR Data [14, 77] 
DMSO 
δ Value (ppm) Groups assigned 
7.108-7.122 4H, 3,4,5,6 Aryl protons 
7.463 1H, CONH protons 
3.412 1H, NH protons 
1.237-2.509 2H, CH2CO protons 
0.828-0.856 4H, CH2 protons 
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COMPOUND E 
  
N
H
N
O
N
NH
O
O  
 1-[3-(1H-benzimidazol-2-yl)propanoyl]tetrahydropyridazine-3,6-dione 
IR Spectral data [14, 77] 
KBr pellet 
IR value (cm-1) Groups assigned 
2671.73 Alkyl C-H Stretching 
1437.72 Aromatic C=C Stretching 
749.55 Aromatic C-H Bending 
1609.74 C=O Stretching 
1222.85, 1152.40 Alkyl C-N Stretching 
1276.29, 1320.13 Aromatic C-N Stretching 
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NMR Data [14, 77] 
DMSO 
δ Value (ppm) Groups assigned 
7.103-7.125 4H, 3,4,5,6 Aryl protons 
7.469 1H, CONH protons 
3.412 1H, NH protons 
2.509 2H, COCH2 protons 
0.742-1.236 2H, CH2 protons 
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COMPOUND F 
  
N
H
N
O
N
NH
O
O  
2-[3-(1H-benzimidazol-2-yl)propanoyl]-2,3-dihydrophthalazine-1,4-dione 
IR Spectral data [14, 77] 
KBr pellet 
IR value (cm-1) Group assigned 
2851.96, 2921.13 Alkyl C-H Stretching 
3052.00 Aromatic C-H Stretching 
740.36, 749.81 Aromatic C-H Bending 
1450.38, 1436.07 Aromatic C=C Stretching 
1668.52 C=O Stretching 
1154.42, 1222.74 Alkyl C-N Stretching 
1319.75 Aromatic C-N Stretching 
3229.21 N-H Stretching 
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NMR Data [14, 77] 
DMSO 
δ Value (ppm) Groups assigned 
7.461-7.484 4H, Phthalazine protons 
7.451 1H, CONH protons 
7.098-7.126 4H, 3,4,5,6 Aryl protons 
3.424 1H, NH proton 
2.509 2H, COCH2 protons 
1.322 2H, CH2 protons 
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COMPOUND G 
   
N
H
N
O
N
N
SH  
  5-[2-(1H-benzimidazol-2-yl)ethyl]-1,3,4-oxadiazole-2-thiol 
IR Spectral data [14, 77] 
KBr pellet 
IR value (cm-1) Groups assigned 
2921.33, 2854.88 Alkyl C-H Stretching 
1570.23, 1497.07 Aromatic C=C Stretching 
775.09, 759.09 Aromatic C-H Stretching 
1277.78, 1301.02, 1326.99 C-N Stretching 
3435.65 N-H Stretching 
1627.53 N-H Bending 
1069.54 C-O-C Stretching 
2732.37 S-H 
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NMR Data [14, 77] 
DMSO 
δ Value (ppm) Groups assigned 
7.484-7.507 4H, 3,4,5,6 Aryl protons 
3.444 1H, NH proton 
2.509 1H, SH proton 
0.834-1.040 2H, CH2 protons 
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COMPOUND H 
   
N
H
N
O
N
N
NH2  
  5-[2-(1H-benzimidazol-2-yl)ethyl]-1,3,4-oxadiazol-2-amine 
IR Spectral data [14, 77] 
KBr pellet 
IR value (cm-1) Group assigned 
1451.38, 1435.74 Aromatic C=C Stretching 
739.35, 848.52 Aromatic C-H bending 
1275.62, 1223.11 C-N Stretching 
3274.08, N-H Stretching 
1543.28, 1654.64 N-H bending 
1031.67 C-O-C Stretching 
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NMR Data [14, 77] 
DMSO 
δ Value (ppm) Groups assigned 
7.087-7.108 4H, 3,4,5,6 Aryl protons 
3,434 1H, NH proton 
2.509 2H, CH2 protons 
1.637 2H, NH2 protons 
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ANALGESIC ACTIVITY 
             Analgesic activity of various synthetic drugs was evaluated by 
acetic acid induced writhing reflux in mice. Painful reaction in animals may be 
produced by the chemicals such as phenylquinone, bradykinin etc.  Like that, 
acetic acid pain reaction which is characterized as a writhing response. 
Construction of abdomen, turning of trunk (twist) and extension of hind legs 
are taken as reaction to chemically induced pain. Analgesics (both narcotic and 
non-narcotic) inhibit writhing response. 
REQUIREMENTS: 
Animal                                : Swiss albino mice (20-25g) either sex 
Drugs and chemicals          :     Diclofenac sodium (standard), 
                                             Acetic acid (1%v/v), various synthetic compounds 
    such as A to H 
                                             
METHOD: 
TREATMENT PROTOCOL 
Group-1 Treated as normal control received 10ml/kg of normal saline through 
orally. 
Group-2 Treated as Standard control received 10mg/kg of diclofenac sodium 
through Intraperitonially. 
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Group-3 Treated as treatment control received 10mg/kg of synthetic drug 
comp-A dissolved with 0.5ml of DMSO administered through 
intraperitonially. 
Group-4 Treated as treatment control received 10mg/kg of synthetic drug 
comp-B dissolved with 0.5ml of DMSO administered through 
intraperitonially. 
Group-5 Treated as treatment control received 10mg/kg of synthetic drug 
comp-C dissolved with 0.5ml of DMSO administered through 
intraperitonially. 
Group-6 Treated as treatment control received 10mg/kg of synthetic drug 
comp-D dissolved with 0.5ml of DMSO administered through 
intraperitonially. 
Group-7 Treated as treatment control received 10mg/kg of synthetic drug 
comp-E dissolved with 0.5ml of DMSO administered through 
intraperitonially. 
Group-8 Treated as treatment control received 10mg/kg of synthetic drug 
comp-F dissolved with 0.5ml of DMSO administered through 
intraperitonially. 
Group-9 Treated as treatment control received 10mg/kg of synthetic drug 
comp-G dissolved with 0.5ml of DMSO administered through 
intraperitonially. 
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Group-10 Treated as treatment control received 10mg/kg of synthetic drug 
comp-H dissolved with 0.5ml of DMSO administered through 
intraperitonially. 
 All the synthetic drugs were administered half hour prior to the acetic 
acid administration. Note the onset on writhing. Record the numbers of 
abdominal contractions, trunk twist and extension of hind limbs as well as the 
number of animals showing such response during a period of 10 minutes were 
noted. 
 STATISTICS: 
 Data are expressed as mean ± SEM; data analyzed by one way ANOVA 
followed by Newman’s keul’s multiple range tests to determine the 
significance of the difference between the control group and rats treated with 
the extracts. 
  *   Values were considered significant at P< 0.01.  
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TABLE No.5 
ANALGESIC ACTIVITY OF VARIOUS SYNTHETIC DRUGS 
Treatment Dose (mg/kg) No. of writhing 
% reduction in 
reaction time 
Group I 
Normal control 
Inject 1%v/v acetic 
acid 1ml/100g of 
body weight 
37.0±3.2 - 
Group II 
Std control 
10mg/kg  
I.P.Diclofenac 
sodium 
6.0±0.8 83.78%* 
Group III 
Treatment control 
10mg/kg comp-A 
through I.P. 
13.2±1.68 64.32%* 
Group IV 
Treatment control 
10mg/kg comp-B 
through I.P.  
12.6±1.24 65.94%* 
Group V 
Treatment control 
10mg/kg comp-C 
through I.P.  
13.2±1.68 64.32%* 
Group VI 
Treatment control 
10mg/kg comp-D 
through I.P.  
13.4±1.98 63.78%* 
Group VII 
Treatment control 
10mg/kg comp-E 
through I.P.  
12.9±1.62 65.13%* 
Group VIII 
Treatment control 
10mg/kg comp-F 
through I.P.  
12.9±1.62 65.13%* 
Group IX 
Treatment control 
10mg/kg comp-G 
through I.P.  
14.0±2.06 62.16%* 
Group X 
Treatment control 
10mg/kg comp-H 
through I.P.  
14.05±2.26 62.02%* 
 
Values are expressed as mean±SEM 
Values were find out by using one-way ANOVA followed by Newman’s keuls 
multiple range tests. 
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*   Values were considered significant at P< 0.01. 
 
RESULTS 
 The table values show that analgesic activity of various synthetic 
compound such as comp A – H by acetic acid induced writhing reflex. The 
results reveals that all synthetic drugs possess significant analgesic activity at 
p<0.01.  
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ANTI-INFLAMMATORY ACTIVITY 
 The anti-inflammatory activities of synthetic drugs at a dose of 10 mg/kg 
doses were evaluated using carrageenan-induced paw edema method. The 
inflammation was readily produced in the form of edema with the help of 
irritant such as carrageenan. Carrageenan is a sulphated polysaccharide 
obtained from sea weed (Rhodophyceae) and when injected cause the release 
of prostaglandins by the way it produces inflammation and edema. 
REQUIREMENTS: 
Animal   : Albino rat (180-200 g) 
Drugs and chemicals : Carrageenan (1%w/v), Diclofenac sodium  
      (standard), DMSO 
                                            Digital plethysmo meter. U G O Basile (Italy) 
Test compounds  :   Synthetic drugs such as A to H. 
METHOD: 
  The animals were divided into 10 groups each having six animals. A 
freshly prepared suspension of carrageenan (1% w/v, 0.1 ml) was injected to 
the planter region of left hind paw of each rat. One group was kept as control 
and the animals of the other groups were pretreated with Synthetic drugs such 
as A to H test Compounds dissolved with 0.5 ml DMSO administered through 
intraperitonially 30 min before the carrageenan treatment. The paw volumes of 
the test compounds, standard and control groups were measured at 60,240,360 
minutes of carrageenan treatment with the help of Digital plethysmometer 
(Ugo basile, Italy). Mean increase in paw volume was measured and the 
percentage of inhibition was calculated. 
% Anti-inflammatory activity = (Vc-Vt / Vc) x 100 
Where, Vt- means increase in paw volume in rats treated with test compounds, 
 Vc- means increase in paw volume in control group of rats. 
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TABLE No.6 
ANTI-INFLAMMATORY ACTIVITY OF SYNTHETIC DRUGS 
Treatment Dose (mg/kg) 
Paw volume(ml) 
as measured by 
mercury 
displacement at 6 
hour 
Percentage 
inhibition of paw 
edema 
Group I 
Normal saline 
10ml/kg orally 5.90±0.90 - 
Group II 
   Std 
10mg/kg 
I.P.Diclofenac 
sodium 
1.72±0.43 70.84%*a 
Group III 
   (A) 
10mg/kg.i.p. 2.50±0.42 57.62%*a 
Group IV 
   (B) 
10mg/kg.i.p.  2.08±0.28 64.74%*a 
Group V 
   (C) 
10mg/kg.i.p.  2.10±0.33 64.40%*a 
Group VI 
   (D) 
10mg/kg.i.p.  2.42±0.38 58.98%*a 
Group VII 
   (E) 
10mg/kg.i.p.  2.10±0.33 64.40%*a 
Group VIII 
   (F) 
10mg/kg.i.p.  2.04±0.30 65.42%*a 
Group IX 
   (G) 
10mg/kg.i.p.  2.60±0.48 55.93%*a 
Group X 
   (H) 
10mg/kg.i.p.  2.64±0.50 55.25%*a 
* Data are expressed as Mean ± S.E.M. 
*Data were analyzed by one way ANOVA followed by Newman’s keul’s 
multiple range tests, to determine the significance of the difference between 
the control group and rats treated with the test compounds. 
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*a   Values were significantly different from normal control at P< 0.01. 
 
RESULTS 
 Various synthetic drugs such as A to H  at a dose of 10mg/kg were 
tested for their Anti- inflammatory activity by using carrageenan Induced rat 
paw edema method and the results are tabulated in table no 1.  The results 
reveals that   synthetic drugs A to H at 10mg/kg doses possesses significant 
Anti- inflammatory activity when compared to control group at p<0.01.  
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ANTIMICROBIAL STUDIES 
Organism used 
 Gram +ve microorganism : Staphylococcus aureus 
Gram –ve microorganism : Pseudomonas aurogenosa 
Fungi microbial  : Candida albicans 
 
Media used 
Muller-Hinton agar media  
Saboured Dextrose Agar media 
 
Standard used 
Amikacin disc 
Ketoconazole 
 
Method 
Filter paper disc method 
Principle 
      Gel diffusion 
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ANTIBACTERIAL ACTIVITY 
 They have relatively broad spectrum of action and are effective against 
Gram positive and Gram negative organism. 
Bacteria 
 Bacteria are unicellular microscopic prokaryotic organism lacking 
chlorophyll. They are found in animals, plant, soil, water, atmosphere and 
dead organic matters. Bacteria generally vary in size from 0.5µ to 3µ. 
Infection 
  Infection can involve in any organs or system in body. The present trend is to 
refer to all disease caused by living micro organism as infectious diseases.  
• Bacteristatic if it inhibits the growth of bacteria 
• Bactericidal if it destroys and kills the bacteria 
Treatment 
  Chemotherapy is defined as the treatment of specific infections with 
chemical agents so as to destroy offending micro organism or parasites without 
damaging the caused tissues.  
Mechanism of action of antibacterial agents 
• Interference with cell wall synthesis 
• Damage to the cytoplasmic membrane 
• Inhibition of protein synthesis and impairment of function of the ribosome 
• Interference with translation of genetic information 
• Inhibition of viral enzymes 
Experimental 
Purpose and rationale 
 The in vitro antibacterial activities of the various synthesized 
benzimidazole derivatives were evaluated against staphylococcus aureus and 
pseudomonas aurogenosa. 
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Requirements 
• Petri dish (sterilized) 
• Muller-Hinton agar media (sterilized) 
• Amikacin disc (standard) 
• Dimethyl sulphoxide (control) 
• Synthesized compound 1-8 (A-H) 
Organism used 
Gram +ve microorganism  
Staphylococcus aureus 
Gram –ve microorganism  
Pseudomonas aurogenosa 
Method: Filter paper disc method 
Principle: Gel diffusion 
Composition of media: Muller-Hinton agar media 
Beef extract               30gm 
Peptone                     17.5gm 
Starch                        1.5gm 
Agar                          17gm 
Sodium hydroxide     5gm 
Distilled water          1000ml 
Final pH at 25°C        7.4±0.2 
 The beef extract, peptone, starch and agar were taken in the above 
proportions and dissolved up to 100ml of distilled water. The constituents 
were heated gently at 100°C with agitation. The pH of the medium was 
adjusted to 7.4 using sodium hydroxide. The pH tested using a universal 
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indicator paper, which showed green colour at pH 7.4, and then it was 
transferred to boiling tubes in hot conditions and sealed with non absorbent 
cotton and sterilized by autoclaving at 121°C (15lbs pressure) for 15 min, 
poured aseptically in to sterile Petri dishes.  
Conditions of the work 
 The entire work was done using horizontal laminar flow cabinet so as to 
provide aseptic condition. Before commencement of the work, air sampling 
was carried using a sterile Mull- Hinton agar plate and exposing in to the 
environment inside the cabinet. On incubation it was checked for the growth of 
micro organism and absence of growth confirmed the aseptic working 
conditions. 
Inoculation of microorganism 
  The sterilized Muller-Hinton agar media was heated on a water bath to melt 
the media. When the media was luke warm, the organism was inoculated 
separately and poured aseptically into sterile petridishes and allowed to 
solidify. The standard drug Amikacin disc was placed on the media and the 
Whatmann No.2 filter disc (5mm diameter) were cut and filled into vials 
plugged with cotton. These vials were kept in hot air oven at 160°C for 30 min 
for sterilization. Then it was soaked in synthesized compounds separately and 
evaporated to dryness and kept on the media (5mm height).  One more disc 
immersed in dimethyl sulphoxide and kept on the media as control. It was kept 
in the refrigerator for one hour to facilitate uniform diffusion of the drug and 
later kept in the incubator for a period of 24 hours at 37°C. Observations were 
made for the zone of inhibition around the synthesized compounds with that of 
standard. 
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ANTIBACTERIAL ACTIVITY OF SYNTHESIZED COMPOUNDS 
AGAINST STAPHYLOCOCCUS AUREUS 
Standard- Amikacin Control- DMSO 
Fig 7 
 
 
  
MICROBIOLOGICAL EVALUATION 
 
Dept. Of Ph. Chemistry  Page 92 
 
ANTIBACTERIAL ACTIVITY OF SYNTHESIZED COMPOUNDS 
AGAINST PSEUDOMONAS AUROGENOSA 
Standard- Amikacin Control- DMSO 
Fig 8 
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ANTIBACTERIAL ACTIVITY OF VARIOUS SYNTHESIZED 
COMPOUNDS 
Table No 7. 
Activities against G +ve and G –ve organisms 
Compounds 
 
Zone of inhibition 
Code  G +ve 
S.aureus 
in mm 
(%) 
G –ve 
P.aurogenos
a in mm (%) 
1 (A) 10 15 
2 (B) 12 10 
3 (C) 11 10 
4 (D) 11 13 
5 (E) 14 16 
6 (F) 18 12 
7 (G) 15 11 
8 (H) 17 17 
Control Resistant Resistant 
Standard 17 16 
 
  Standard : Amikacin 
  Control : DMSO 
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ANTIFUNGAL ACTIVITY 
INTRODUCTION 
 Fungi are plant like non photosynthetic eukaryotes growing either in 
colony of single cell (yeast) or in filamentous multi-cellular aggregates 
(molds). Most fungi live as Saprophytes in soil or dead plant materials and 
they are very important in the mineralization of organic matter. Antifungals 
work by exploiting differences between mammalian and fungal cells to kill the 
fungal organism without dangerous effects on the host. Unlike bacteria, 
both fungi and humans are eukaryotes. Thus fungal and human cells are 
similar at the molecular level. This makes it more difficult to find or design 
drugs that target fungi without affecting human cells. 
 The azole antifungal drugs inhibit the enzyme lanosterol 14 α-
demethylase; the enzyme necessary to convert lanosterol to ergosterol. 
Depletion of ergosterol in fungal membrane disrupts the structure and many 
functions of fungal membrane leading to inhibition of fungal growth. 
Treatment  
 The standard drug used is Ketoconazole.  
    
 Ketoconazole is usually prescribed for topical infections such 
as athlete’s foot, ringworm, candidiasis (yeast infection or thrush), and jock 
itch. 
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Experiment 
Purpose and rationale 
 The in-vitro antifungal activity of the various synthesized benzimidazole 
derivatives were evaluated on Candida albicans. 
Requirement 
• Petri-dishes (sterilized) 
• Sabouraud Dextrose Agar media (sterilized) 
• Ketoconazole (standard) 
• DMSO (control) 
• Synthesized compounds 
Organisms used 
 Candida albicans 
Method 
 Filter paper disc method 
Principle 
 Gel diffusion 
Composition of media 
 Saboured Dextrose Agar media 
 Glucose   -40gm 
 Peptone   -10gm 
 Agar   -15gm 
 Distilled water up to -1000ml 
 Final pH  -5.4 
 
Procedure 
 Glucose, peptone and agar were taken in the above proportions and 
dissolved up to 1000ml of distilled water. The constituents were heated gently 
at 100°C with agitation. The pH of the media was adjusted to 5.4. Then it was 
transformed to boiling tube in hot condition and sealed with non-absorbent 
cotton and sterilized by autoclaving at 121°C (15 lbs pressure) for 15 minutes 
then poured aseptically in to sterile Petri-dishes. 
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Microorganisms- Candida albicans 
 Candida albicans is seldom isolated outside the bodies of animals and is 
known from 58 species including wild and domestic mammals and birds. 
Candiasis, the disease caused by C.albicans. The cell wall polysaccharides 
mannan and mannan protein complexes are involved in several different 
interaction and mannan structure types of Candida albicans.  
Working conditions 
 The entire work was done using horizontal laminar flow cabinet so as to 
provide aseptic condition before commencement of work, a sampling was 
carried out using a sterile Muller-Hinton agar plate and exposing it to the 
environment inside the cabinet. On incubation it was checked for the growth of 
microorganism and absence of growth confirmed the aseptic working 
condition 
Inoculation of microorganism 
 For the screening of antifungal activity disc diffusion method was used. 
Sabouraud dextrose agar plate were prepared aseptically to get a thickness of 
5-6mm. the plates were allowed to solidify and inverted to prevent the 
condensate falling on the agar surface. The plates were dried at 37°C just 
before inoculation. 
 From the solid culture the clinical sample of Candida albicans were 
inoculated in to Sabouraud dextrose agar plates by using sterile inoculation 
loop and agar plates were incubated for about 24 hours, at 37°C, which show 
significant growth of fungi. 
 The temperature of the medium should not exceed about 50°C when the 
organisms were inoculated. The standard drug Ketoconazole (10µgm/disc) 
was placed on the media. The sterile Whatmann No.2 filter paper disc (5mm 
diameter) was soaked in synthesized compound (20µgm/disc) separately and 
evaporated to dryness and then kept on the media. One more disc immersed in 
dimethyl sulphoxide and kept on the media as control. The Petri dishes were 
incubated at 37°C for 24 hours, after placing them in refrigerator for 1 hour to 
facilitate uniform diffusion. Observations were made for the zone of inhibition 
around the synthesized compound and with that of standard. 
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ANTIFUNGAL ACTIVITY OF SYNTHESIZED COMPOUNDS 
AGAINST CANDIDA ALBICANS 
Standard- Ketoconazole  Control- DMSO 
Fig 9 
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ANTIFUNGAL ACTIVITY OF VARIOUS SYNTHESIZED 
COMPOUNDS 
Table No8 
Microorganism used –Candida albicans 
 
Compounds code Zone of inhibition in 
mm 
1 (A) 14 
2 (B) 12 
3 (C) 15 
4 (D) 11 
5 (E) 10 
6 (F) 12 
7 (G) 16 
8 (H) 12 
Control Resistant 
Standard 15 mm 
 
Standard –Ketoconazole 
Control  – DMSO 
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RESULTS AND DISCUSSION 
i. Molecular docking studies 
 Various ligands were designed by replacing the carboxylic acid group 
present in the prepared 3-(1H-benzimidazole-2-yl) propeonic acid and its 
binding affinity in COX-2 and 14 α-demethylase were determined with the 
help of molecular docking studies using Argus Lab program.  The binding 
scores of designed ligands 1-8 with COX-2 and 14 α-demethylase enzymes 
ranging from -12.8915 to -9.37935 Kcal/Mol and -8.91847 to -6.81676 
Kcal/Mol respectively (see table no) and the binding modes of these ligands 
with COX-2 and 14 α-demethylase enzymes are given in Fig . These data 
clearly indicates their potency as Cyclooxygenase inhibitor and 14 α-
demethylase inhibitor. Almost all the designed ligands showed good 
interaction energy. 
ii. Characterization of synthesized compounds 
 The selected ligands 1-8 which showed good interaction energy were 
designed and then characterized by various methods such as Infra red 
Spectrometry (IR), and Nuclear Magnetic Resonance (NMR) and its reports 
were in complete arrangement with their chemical structure. The purity of the 
synthesized compounds was further established by chromatographic methods 
(TLC). 
iii. Pharmacological studies 
 The pharmacological screening of these derivatives were carried out 
according to standard procedure and compared with standard. 
a) Analgesic activity 
 All the synthesized compounds were tested for their analgesic 
activity by using acetic acid induced writhing reflux in mice and the 
results are tabulated in table no.5. The results reveals that all the 
compounds possess significant analgesic activity when compared to 
control group at p<0.01. 
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b) Anti-inflammatory activity 
 All the synthesized compounds were also tested for their anti-
inflammatory activity by using carrageenan induced rat paw edema 
method and the results are tabulated in table no.6. The results reveals 
that the synthetic drugs A to H at 10mg/kg doses possesses significant 
Anti- inflammatory activity when compared to control group at p<0.01. 
c) Antimicrobial activity 
 All the synthesized compounds were tested for antimicrobial 
activity like antibacterial and antifungal activity. Antibacterial activity 
was evaluated against Streptococcus aureus (G +ve) and Pseudomonas 
aerogenosa (G –ve). Antifungal activity was evaluated against Candida 
albicans. The zone of inhibition was measured as the parameter of 
activity. 
Staphylococcus aureus (G+ve) - Antibacterial activity was evaluated 
against Staphylococcus aureus and the zone of inhibition was 
measured. Amikacin, the standard showed a zone of inhibition of 17 
mm. Out of 8 synthesized compounds three (F and H) showed high 
degree of activity and two (E and G) showed considerable activity and 
the remaining four compounds showed moderate activity when 
compared with standard. The results are tabulated in table no.7. 
Pseudomonas aerogenosa- Antibacterial activity was evaluated 
against Pseudomonas aerogenosa and the zone of inhibition was 
measured. Amikacin, the standard showed a zone of inhibition of 16 
mm. Out of 8 synthesized compounds three (A, E, H) showed high 
degree of activity and two (D and F) showed considerable activity and 
the remaining compounds showed moderate activity when compared 
with standard. The results are tabulated in table no 7. 
Candida albicans- Antifungal activity was evaluated against Candida 
albicans and the zone of inhibition was measured. Ketoconazole, the 
standard showed a zone of inhibition of 15 mm. Out of 8 synthesized 
compounds three (A, C, G) showed high degree of activity and 
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remaining five showed moderate activity when compared with the 
standard. The results are tabulated in table no 8. 
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CONCLUSION 
 Various pyridazine-3,6-dione, 2,3-dihydrophthalazine-1,4-dione, 1,3,4-
oxadiazole derivatives of 3-(1H-benzimidazol-2-yl)propanoic acid were 
designed and synthesized with the aim of developing better analgesic anti-
inflammatory molecules with antimicrobial activity. 
 The results generated in this study leads to the following conclusions. 
• Molecular docking studies reveal that all the designed ligands 1-
8 possess very good binding ability in COX-2 and 14 α-
demethylase enzymes. 
• All the test compounds exhibit significant analgesic activities 
against acetic acid induced writhing reflux. 
• All the test compounds exhibit significant anti-inflammatory 
activity in carrageenan induced rat paw edema method. 
• The test compounds A, F, E, H showed high degree of 
antibacterial activity when compared with standard Amikacin 
and test compounds A, C, G showed high degree of antifungal 
activity against when compared with standard Ketoconazole. 
The result obtained support the statement that newly synthesized heterocyclic 
analogues of benzimidazole can be considered as good analgesic anti-
inflammatory agent with antimicrobial activity, however further structural 
modification are planned to increase the activity of this series to obtain a 
clinically useful antimicrobial, analgesic and anti-inflammatory agent. 
